Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$653M |
| 2 |
Amazon
AMZN
|
+$602M |
| 3 |
ExxonMobil
XOM
|
+$473M |
| 4 |
Tesla
TSLA
|
+$437M |
| 5 |
Starbucks
SBUX
|
+$380M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$511M |
| 2 |
Netflix
NFLX
|
+$427M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$397M |
| 4 |
Nike
NKE
|
+$373M |
| 5 |
Microsoft
MSFT
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.68% |
| 2 | Healthcare | 17.69% |
| 3 | Consumer Discretionary | 13.09% |
| 4 | Industrials | 7.96% |
| 5 | Consumer Staples | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GTH
2951
DELISTED
Genetron Holdings Limited ADS
GTH
| $328K | ﹤0.01% |
89,227
+38,527
| +76% | +$134K |
|
|
BRSP
2952
BrightSpire Capital
BRSP
$633M
| $327K | ﹤0.01% |
+44,000
| New | +$287K |
|
|
HDV
2953
iShares Core High Dividend ETF
HDV
$15.1B
| $326K | ﹤0.01% |
+16,000
| New | +$315K |
|
2954
Aligos Therapeutics
ALGS
$41.7M
| $325K | ﹤0.01% |
19,598
+6,744
| +52% | +$116K |
|
2955
TMC The Metals Company
TMC
$1.71B
| $323K | ﹤0.01% |
293,400
-331,136
| -53% | -$342K |
|
2956
Invesco S&P MidCap Momentum ETF
XMMO
$7.68B
| $323K | ﹤0.01% |
+3,600
| New | +$296K |
|
2957
Arcturus Therapeutics
ARCT
$232M
| $322K | ﹤0.01% |
10,202
-169,498
| -94% | -$4.03M |
|
|
BNR
2958
Burning Rock Biotech
BNR
$96M
| $321K | ﹤0.01% |
34,530
-670
| -2% | -$6.16K |
|
|
CRESY
2959
Cresud
CRESY
$746M
| $321K | ﹤0.01% |
+34,122
| New | +$279K |
|
2960
iShares iBonds Dec 2027 Term Corporate ETF
IBDS
$3.87B
| $320K | ﹤0.01% |
+13,389
| New | +$312K |
|
2961
Innospec
IOSP
$2.31B
| $320K | ﹤0.01% |
+2,600
| New | +$277K |
|
2962
Urban One Class A
UONE
$23.9M
| $320K | ﹤0.01% |
7,950
+2,340
| +42% | +$110K |
|
2963
American Realty Investors
ARL
$246M
| $319K | ﹤0.01% |
18,299
-800
| -4% | -$11.7K |
|
2964
Atara Biotherapeutics
ATRA
$73.9M
| $319K | ﹤0.01% |
24,916
-8,248
| -25% | -$192K |
|
2965
Shinhan Financial Group
SHG
$35.4B
| $317K | ﹤0.01% |
10,300
-27,800
| -73% | -$764K |
|
|
ZFOX
2966
DELISTED
ZeroFox Holdings, Inc. Common Stock
ZFOX
| $317K | ﹤0.01% |
364,605
+262,635
| +258% | +$180K |
|
|
LND
2967
BrasilAgro
LND
$351M
| $316K | ﹤0.01% |
59,900
+44,600
| +292% | +$232K |
|
2968
SR Bancorp
SRBK
$146M
| $315K | ﹤0.01% |
+33,000
| New | +$295K |
|
|
YI
2969
111 Inc
YI
$33.4M
| $315K | ﹤0.01% |
20,302
+6,127
| +43% | +$128K |
|
2970
ReWalk Robotics
LFWD
$21.2M
| $315K | ﹤0.01% |
4,824
+1,824
| +61% | +$109K |
|
2971
SurgePays
SURG
$7.56M
| $314K | ﹤0.01% |
+48,700
| New | +$259K |
|
|
SHCR
2972
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
| $314K | ﹤0.01% |
290,700
+172,600
| +146% | +$177K |
|
2973
Spire Global
SPIR
$535M
| $312K | ﹤0.01% |
39,857
-23,924
| -38% | -$122K |
|
|
TIO
2974
DELISTED
Tingo Group, Inc. Common Stock
TIO
| $312K | ﹤0.01% |
902,921
-171,000
| -16% | -$138K |
|
2975
WisdomTree US MidCap Dividend Fund
DON
$4.12B
| $311K | ﹤0.01% |
6,800
-3,900
| -36% | -$164K |
|
Similar funds
Jim Simons's Q4 2023 Portfolio in Review
As of Q4 2023, Jim Simons held 4,318 positions worth $64.6B, up 10% from $58.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons's Q4 2023 filing shows 702 new, 1,590 increased, 1,355 reduced and 633 closed positions. Its largest new stake was Amazon: 4,296,466 shares worth $653M. The largest sale was Berkshire Hathaway Class A, an estimated $511M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2023 buy was Amazon: 4,296,466 shares worth $653M.
- Jim Simons added most to Meta Platforms (Facebook) in Q4 2023, an estimated $653M increase.
- Jim Simons's biggest Q4 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $511M.
- Jim Simons fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $397M.
- Jim Simons's ten largest holdings make up 12% of its $64.6B portfolio in Q4 2023.
- Jim Simons opened 702 new positions and closed 633 in Q4 2023.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $64.6B.
Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.